FREDUN PHARMACEUTICALS
Back to All Ratios
|
FREDUN PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PCE(x) | 12.50 | 17.36 | 25.87 | 47.78 | 46.02 |
What is the latest Price to Cash Earnings (PCE) ratio of FREDUN PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2025 | 12.50 |
| Mar2024 | 17.36 |
| Mar2023 | 25.87 |
| Mar2022 | 47.78 |
| Mar2021 | 46.02 |
How is Price to Cash Earnings (PCE) of FREDUN PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2025 | 12.5 | -28.00 | |
| Mar2024 | 17.36 | -32.90 | |
| Mar2023 | 25.87 | -45.86 | |
| Mar2022 | 47.78 | 3.82 | |
| Mar2021 | 46.02 | - | |
Other Financial Ratios of FREDUN PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹743.2 Cr | -11.2% | -7.1% | 123.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | -0.1% | 3.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,614.0 Cr | 1.6% | -2.5% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,245.0 Cr | 0.8% | -0.9% | 13.5% | Stock Analytics | |
| CIPLA | ₹122,555.0 Cr | 1.3% | -0.6% | 3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,803.0 Cr | 1% | 3.7% | 2.7% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -11.2% |
-7.1% |
123.1% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses